Insights on CXC chemokine receptor 2 in breast cancer: An emerging target for oncotherapy

Breast cancer is the most common malignant neoplasm in women worldwide, and the treatment regimens currently available are far from optimal. Targeted therapy, based on molecular typing of breast cancer, is the most precise form of treatment, and CXC chemokine receptor 2 (CXCR2) is one of the molecul...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Fengzhu, Long, Lang, Wang, Jiantao, Wang, Yuyi, Liu, Yanyang, Wang, Li, Luo, Feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6865047/
https://www.ncbi.nlm.nih.gov/pubmed/31788042
http://dx.doi.org/10.3892/ol.2019.10957

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6865047/
https://www.ncbi.nlm.nih.gov/pubmed/31788042
http://dx.doi.org/10.3892/ol.2019.10957

Ejemplares similares